Zila to Report Second Quarter Fiscal 2008 Financial Results and Host Investor Conference Call on March 11
March 07 2008 - 3:50PM
Business Wire
Zila, Inc. (Nasdaq: ZILA) today announced that it will release its
financial results for the fiscal 2008 second quarter ended January
31, 2008, after the market closes on Tuesday, March 11, 2008. The
company also said that senior management will host an investor
conference call that day at 1:30 p.m. PT (4:30 p.m. ET) to review
the company�s financial results. The conference call will be
available to interested parties through a live audio Internet
broadcast at www.zila.com and www.opencompany.info. The call will
also be archived and accessible at both sites for approximately 90
days. Alternatively, callers may participate in the conference call
by dialing (866) 250-3615 (domestic) or (303) 262-2142
(international). A telephonic replay will be available for
approximately 48 hours following the conclusion of the call by
dialing (800) 405-2236 (domestic) or (303) 590-3000
(international), and entering passcode 11110484#. About Zila, Inc.
Zila, Inc., is a fully integrated oral diagnostic company dedicated
to the prevention, detection and treatment of oral cancer and
periodontal disease. ViziLite� Plus, the company's flagship product
for the early detection of oral abnormalities that could lead to
cancer, is the first and only adjunctive medical device cleared by
the FDA for use in a population at increased risk for oral cancer.
In addition, Zila designs, manufactures and markets a suite of
proprietary products sold exclusively and directly to dental
professionals for periodontal disease, including the Rota-dent�
Professional Powered Brush, the Pro-Select� Platinum ultrasonic
scaler and a portfolio of oral pharmaceutical products for both
in-office and home-care use. For more information about the company
and its products, please visit www.zila.com.
Zila (NASDAQ:ZILA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zila (NASDAQ:ZILA)
Historical Stock Chart
From Jul 2023 to Jul 2024